We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter International Inc BAX Stock XNYS Rating as of Aug 6, 2025 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation Dividends Ownership ...

Baxter International has voluntarily paused shipments and planned installations of its Novum infusion pump. In April, the FDA reported an underinfusion risk with the company’s Novum IQ large-volume ...

Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.

The stock's fall snapped a four-day winning streak.